{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T08:25:20Z","timestamp":1792571120241,"version":"4.5.0"},"reference-count":59,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,12,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The live yellow fever vaccine (YF-17D) offers a unique opportunity to study memory CD8+ T cell differentiation in humans following an acute viral infection. We have performed a comprehensive analysis of the virus-specific CD8+ T cell response using overlapping peptides spanning the entire viral genome. Our results showed that the YF-17D vaccine induces a broad CD8+ T cell response targeting several epitopes within each viral protein. We identified a dominant HLA-A2-restricted epitope in the NS4B protein and used tetramers specific for this epitope to track the CD8+ T cell response over a 2 year period. This longitudinal analysis showed the following. 1) Memory CD8+ T cells appear to pass through an effector phase and then gradually down-regulate expression of activation markers and effector molecules. 2) This effector phase was characterized by down-regulation of CD127, Bcl-2, CCR7, and CD45RA and was followed by a substantial contraction resulting in a pool of memory T cells that re-expressed CD127, Bcl-2, and CD45RA. 3) These memory cells were polyfunctional in terms of degranulation and production of the cytokines IFN-\u03b3, TNF-\u03b1, IL-2, and MIP-1\u03b2. 4) The YF-17D-specific memory CD8+ T cells had a phenotype (CCR7\u2212CD45RA+) that is typically associated with terminally differentiated cells with limited proliferative capacity (TEMRA). However, these cells exhibited robust proliferative potential showing that expression of CD45RA may not always associate with terminal differentiation and, in fact, may be an indicator of highly functional memory CD8+ T cells generated after acute viral infections.<\/jats:p>","DOI":"10.4049\/jimmunol.0803903","type":"journal-article","created":{"date-parts":[[2009,11,23]],"date-time":"2009-11-23T22:59:20Z","timestamp":1259017160000},"page":"7919-7930","source":"Crossref","is-referenced-by-count":318,"title":["The Yellow Fever Virus Vaccine Induces a Broad and Polyfunctional Human Memory CD8+ T Cell Response"],"prefix":"10.1093","volume":"183","author":[{"given":"Rama S","family":"Akondy","sequence":"first","affiliation":[{"name":"Emory Vaccine Center and the Hope Clinic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan D","family":"Monson","sequence":"additional","affiliation":[{"name":"Emory Vaccine Center and the Hope Clinic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph D","family":"Miller","sequence":"additional","affiliation":[{"name":"Emory Vaccine Center and the Hope Clinic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srilatha","family":"Edupuganti","sequence":"additional","affiliation":[{"name":"Emory Vaccine Center and the Hope Clinic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Teuwen","sequence":"additional","affiliation":[{"name":"Sanofi Pasteur , Lyon,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Wu","sequence":"additional","affiliation":[{"name":"Emory Vaccine Center and the Hope Clinic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farah","family":"Quyyumi","sequence":"additional","affiliation":[{"name":"Emory Vaccine Center and the Hope Clinic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seema","family":"Garg","sequence":"additional","affiliation":[{"name":"Emory Vaccine Center and the Hope Clinic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D","family":"Altman","sequence":"additional","affiliation":[{"name":"Emory Vaccine Center and the Hope Clinic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Del Rio","sequence":"additional","affiliation":[{"name":"Emory Vaccine Center and the Hope Clinic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry L","family":"Keyserling","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Emory University School of Medicine , Atlanta, GA 30022"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Ploss","sequence":"additional","affiliation":[{"name":"Center for the Study of Hepatitis C, Laboratory of Virology and Infectious Disease, Rockefeller University , New York, NY 10065"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles M","family":"Rice","sequence":"additional","affiliation":[{"name":"Center for the Study of Hepatitis C, Laboratory of Virology and Infectious Disease, Rockefeller University , New York, NY 10065"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter A","family":"Orenstein","sequence":"additional","affiliation":[{"name":"Emory Vaccine Center and the Hope Clinic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark J","family":"Mulligan","sequence":"additional","affiliation":[{"name":"Emory Vaccine Center and the Hope Clinic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafi","family":"Ahmed","sequence":"additional","affiliation":[{"name":"Emory Vaccine Center and the Hope Clinic"},{"name":"Department of Microbiology and Immunology"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2009,12,15]]},"reference":[{"key":"2026012811250550200_R1","first-page":"54","article-title":"Immunological memory and protective immunity: understanding their relation.","volume-title":"Science","year":"1996"},{"key":"2026012811250550200_R2","first-page":"251","article-title":"Effector and memory T-cell differentiation: implications for vaccine development.","volume-title":"Nat. Rev. Immunol.","year":"2002"},{"key":"2026012811250550200_R3","first-page":"255","article-title":"Differentiation of memory B and T cells.","volume-title":"Curr. Opin. Immunol.","year":"2006"},{"key":"2026012811250550200_R4","first-page":"146","article-title":"Developing and maintaining protective CD8+ memory T cells.","volume-title":"Immunol. Rev.","year":"2006"},{"key":"2026012811250550200_R5","first-page":"5535","article-title":"Memory CD8 T-cell differentiation during viral infection.","volume-title":"J. Virol.","year":"2004"},{"key":"2026012811250550200_R6","first-page":"106","article-title":"Skewed maturation of memory HIV-specific CD8 T lymphocytes.","volume-title":"Nature","year":"2001"},{"key":"2026012811250550200_R7","first-page":"1405","article-title":"Immunization with vaccinia virus induces polyfunctional and phenotypically distinctive CD8+ T cell responses.","volume-title":"J. Exp. Med.","year":"2007"},{"key":"2026012811250550200_R8","first-page":"5610","article-title":"Selective expression of IL-7 receptor on memory T cells identifies early CD40L-dependent generation of distinct CD8+ memory T cell subsets.","volume-title":"Proc. Natl. Acad. Sci. USA","year":"2004"},{"key":"2026012811250550200_R9","first-page":"16004","article-title":"Antigen-independent memory CD8 T cells do not develop during chronic viral infection.","volume-title":"Proc. Natl. Acad. Sci. USA","year":"2004"},{"key":"2026012811250550200_R10","first-page":"625","article-title":"Functional and genomic profiling of effector CD8 T cell subsets with distinct memory fates.","volume-title":"J. Exp. Med.","year":"2008"},{"key":"2026012811250550200_R11","first-page":"673","article-title":"Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects.","volume-title":"J. Exp. Med.","year":"2005"},{"key":"2026012811250550200_R12","first-page":"205","article-title":"Lessons from the study of T-cell differentiation in persistent human virus infection.","volume-title":"Semin. Immunol.","year":"2004"},{"key":"2026012811250550200_R13","first-page":"708","article-title":"Two subsets of memory T lymphocytes with distinct homing potentials and effector functions.","volume-title":"Nature","year":"1999"},{"key":"2026012811250550200_R14","first-page":"1710","article-title":"Respiratory syncytial virus-specific CD8+ memory T cell responses in elderly persons.","volume-title":"J. Infect. Dis.","year":"2005"},{"key":"2026012811250550200_R15","first-page":"1075","article-title":"Analysis of the frequencies and of the memory T cell phenotypes of human CD8+ T cells specific for influenza A viruses.","volume-title":"J. Infect. Dis.","year":"2003"},{"key":"2026012811250550200_R16","first-page":"379","article-title":"Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections.","volume-title":"Nat. Med.","year":"2002"},{"key":"2026012811250550200_R17","first-page":"1407","article-title":"Phenotypic and functional separation of memory and effector human CD8+ T cells.","volume-title":"J. Exp. Med.","year":"1997"},{"key":"2026012811250550200_R18","first-page":"1045","article-title":"Comparison of the immunogenicity and safety of two 17D yellow fever vaccines.","volume-title":"Am J Trop Med Hyg.","year":"1999"},{"key":"2026012811250550200_R19","first-page":"850","article-title":"Yellow fever: epidemiology and prevention.","volume-title":"Clin. Infect. Dis.","year":"2007"},{"key":"2026012811250550200_R20","first-page":"895","article-title":"Persistence of neutralizing antibody 30\u201335 years after immunization with 17D yellow fever vaccine.","volume-title":"Bull. World Health Organ.","year":"1981"},{"key":"2026012811250550200_R21","first-page":"9197","article-title":"Recombinant yellow fever viruses are effective therapeutic vaccines for treatment of murine experimental solid tumors and pulmonary metastases.","volume-title":"J. Virol.","year":"2000"},{"key":"2026012811250550200_R22","first-page":"3119","article-title":"Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses.","volume-title":"J. Exp. Med.","year":"2008"},{"key":"2026012811250550200_R23","first-page":"1179","article-title":"Live attenuated yellow fever 17D infects human DCs and allows for presentation of endogenous and recombinant T cell epitopes.","volume-title":"J. Exp. Med.","year":"2005"},{"key":"2026012811250550200_R24","first-page":"413","article-title":"Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity.","volume-title":"J. Exp. Med.","year":"2006"},{"key":"2026012811250550200_R25","first-page":"90","article-title":"Activation\/modulation of adaptive immunity emerges simultaneously after 17DD yellow fever first-time vaccination: is this the key to prevent severe adverse reactions following immunization?.","volume-title":"Clin. Exp. Immunol.","year":"2007"},{"key":"2026012811250550200_R26","first-page":"151","article-title":"Human cytotoxic T lymphocyte responses to live attenuated 17D yellow fever vaccine: identification of HLA-B35-restricted CTL epitopes on nonstructural proteins NS1, NS2b, NS3, and the structural protein E.","volume-title":"Virology","year":"2002"},{"key":"2026012811250550200_R27","first-page":"152","article-title":"Detection of TH1\/TH2 cytokine signatures in yellow fever 17DD first-time vaccinees through ELISpot assay.","volume-title":"Cytokine","year":"2008"},{"key":"2026012811250550200_R28","first-page":"710","article-title":"Human effector and memory CD8+ T cell responses to smallpox and yellow fever vaccines.","volume-title":"Immunity","year":"2008"},{"key":"2026012811250550200_R29","first-page":"116","article-title":"Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans.","volume-title":"Nat. Immunol.","year":"2009"},{"key":"2026012811250550200_R30","first-page":"975","article-title":"T-cell epitope mapping by flow cytometry.","volume-title":"Nat. Med.","year":"1998"},{"key":"2026012811250550200_R31","first-page":"270","article-title":"Mapping T cell epitopes by flow cytometry.","volume-title":"Methods","year":"2003"},{"key":"2026012811250550200_R32","first-page":"213","article-title":"SYFPEITHI: database for MHC ligands and peptide motifs.","volume-title":"Immunogenetics","year":"1999"},{"key":"2026012811250550200_R33","first-page":"275","article-title":"CD8+ T cell effector mechanisms in resistance to infection.","volume-title":"Annu. Rev. Immunol.","year":"2000"},{"key":"2026012811250550200_R34","first-page":"1395","article-title":"Direct visualization of antigen-specific CD8+ T cells during the primary immune response to Epstein-Barr virus in vivo.","volume-title":"J. Exp. Med.","year":"1998"},{"key":"2026012811250550200_R35","first-page":"1191","article-title":"Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells.","volume-title":"Nat. Immunol.","year":"2003"},{"key":"2026012811250550200_R36","first-page":"975","article-title":"Phenotype and function of human T lymphocyte subsets: consensus and issues.","volume-title":"Cytometry A","year":"2008"},{"key":"2026012811250550200_R37","first-page":"309","article-title":"PD-1 and its ligands in T-cell immunity.","volume-title":"Curr. Opin. Immunol.","year":"2007"},{"key":"2026012811250550200_R38","first-page":"682","article-title":"Restoring function in exhausted CD8 T cells during chronic viral infection.","volume-title":"Nature","year":"2006"},{"key":"2026012811250550200_R39","first-page":"425","article-title":"Adhesion receptors of the immune system.","volume-title":"Nature","year":"1990"},{"key":"2026012811250550200_R40","first-page":"5455","article-title":"Identification of naive or antigen-experienced human CD8+ T cells by expression of costimulation and chemokine receptors: analysis of the human cytomegalovirus-specific CD8+ T cell response.","volume-title":"J. Immunol.","year":"2002"},{"key":"2026012811250550200_R41","first-page":"1027","article-title":"Evidence that human CD8+CD45RA+CD27\u2212 cells are induced by antigen and evolve through extensive rounds of division.","volume-title":"Int. Immunol.","year":"1999"},{"key":"2026012811250550200_R42","first-page":"1148","article-title":"Cutting edge: cytolytic effector function in human circulating CD8+ T cells closely correlates with CD56 surface expression.","volume-title":"J. Immunol.","year":"2000"},{"key":"2026012811250550200_R43","first-page":"2711","article-title":"Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T cells.","volume-title":"Blood","year":"2003"},{"key":"2026012811250550200_R44","first-page":"65","article-title":"Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation.","volume-title":"J. Immunol. Methods","year":"2003"},{"key":"2026012811250550200_R45","first-page":"1061","article-title":"HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors.","volume-title":"Nat. Immunol.","year":"2002"},{"key":"2026012811250550200_R46","first-page":"8960","article-title":"Low CD8 T-cell proliferative potential and high viral load limit the effectiveness of therapeutic vaccination.","volume-title":"J. Virol.","year":"2005"},{"key":"2026012811250550200_R47","first-page":"4260","article-title":"Proliferation and differentiation potential of human CD8+ memory T-cell subsets in response to antigen or homeostatic cytokines.","volume-title":"Blood","year":"2003"},{"key":"2026012811250550200_R48","first-page":"514","article-title":"Do most lymphocytes in humans really reside in the gut?.","volume-title":"Trends Immunol.","year":"2007"},{"key":"2026012811250550200_R49","first-page":"e91","article-title":"The immune epitope database and analysis resource: from vision to blueprint.","volume-title":"PLoS Biol.","year":"2005"},{"key":"2026012811250550200_R50","first-page":"7193","article-title":"Dissociation between epitope hierarchy and immunoprevalence in CD8 responses to vaccinia virus Western Reserve.","volume-title":"J. Immunol.","year":"2008"},{"key":"2026012811250550200_R51","first-page":"e343","article-title":"Prolonged activation of virus-specific CD8+ T cells after acute B19 infection.","volume-title":"PLoS Med.","year":"2005"},{"key":"2026012811250550200_R52","first-page":"7550","article-title":"Diversity in the acute CD8 T cell response to vaccinia virus in humans.","volume-title":"J. Immunol.","year":"2005"},{"key":"2026012811250550200_R53","first-page":"60","article-title":"Live attenuated chimeric yellow fever dengue type 2 (ChimeriVax-DEN2) vaccine: phase I clinical trial for safety and immunogenicity: effect of yellow fever pre-immunity in induction of cross neutralizing antibody responses to all 4 dengue serotypes.","volume-title":"Hum. Vaccin.","year":"2006"},{"key":"2026012811250550200_R54","first-page":"1213","article-title":"Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen.","volume-title":"J. Infect. Dis.","year":"2003"},{"key":"2026012811250550200_R55","first-page":"6694","article-title":"A live, attenuated recombinant West Nile virus vaccine.","volume-title":"Proc. Natl. Acad. Sci. USA","year":"2006"},{"key":"2026012811250550200_R56","first-page":"2567","article-title":"Viral vectors for malaria vaccine development.","volume-title":"Vaccine","year":"2007"},{"key":"2026012811250550200_R57","first-page":"201","article-title":"Yellow fever 17D as a vaccine vector for microbial CTL epitopes: protection in a rodent malaria model.","volume-title":"J. Exp. Med.","year":"2005"},{"key":"2026012811250550200_R58","first-page":"165","article-title":"Broadening the horizons for yellow fever: new uses for an old vaccine.","volume-title":"J. Exp. Med.","year":"2005"},{"key":"2026012811250550200_R59","first-page":"8431","article-title":"Immunodominance of poxviral-specific CTL in a human trial of recombinant-modified vaccinia Ankara.","volume-title":"J. Immunol.","year":"2005"}],"container-title":["The Journal of Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/183\/12\/7919\/62693443\/0150.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/183\/12\/7919\/62693443\/0150.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T16:27:03Z","timestamp":1769617623000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jimmunol\/article\/183\/12\/7919\/8053363"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":59,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2009,12,15]]},"published-print":{"date-parts":[[2009,12,15]]}},"URL":"https:\/\/doi.org\/10.4049\/jimmunol.0803903","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.2711956.2375054","asserted-by":"object"}]},"ISSN":["1550-6606","0022-1767"],"issn-type":[{"value":"1550-6606","type":"electronic"},{"value":"0022-1767","type":"print"}],"subject":[],"published-other":{"date-parts":[[2009,12]]},"published":{"date-parts":[[2009,12]]}}}